LIXT (Lixte Biotechnology Holdings, Inc. Common Stock) Stock Analysis

Lixte Biotechnology Holdings, Inc. Common Stock (LIXT) is a publicly traded Healthcare sector company. As of May 21, 2026, LIXT trades at $5.53 with a market cap of $54.60M and a P/E ratio of 0.00. LIXT moved +1.90% today. Year to date, LIXT is +48.15%; over the trailing twelve months it is +327.48%. Its 52-week range spans $0.64 to $6.26. Rallies surfaces LIXT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest LIXT stock research?

Lixte Biotechnology Holdings, Inc. Common Stock (LIXT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LIXT moved +1.90% today.

LIXT Key Metrics

Key financial metrics for LIXT
MetricValue
Price$5.53
Market Cap$54.60M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$6.26
52-Week Low$0.64
Volume101.55K
Avg Volume0
Revenue (TTM)$0
Net Income$-6.01M
Gross Margin0.00%

Latest LIXT News

Recent LIXT Insider Trades

  • Bernards Rene bought 5.53K (~$13.87K) on Oct 3, 2023.
  • van der Baan Bastiaan Jeroen bought 10.00K (~$28.00K) on Oct 3, 2023.
  • Bernards Rene bought 5.53K (~$13.87K) on Oct 3, 2023.

LIXT Analyst Consensus

LIXT analyst coverage data. Average price target: $0.00.

Common questions about LIXT

What can I research for LIXT on Rallies?
Lixte Biotechnology Holdings, Inc. Common Stock (LIXT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LIXT moved +1.90% today.
Does Rallies show live market data for LIXT?
Rallies combines live market context with ticker research for LIXT, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
LIXT

LIXT